Variations in vascular anatomy in knockout mouse strains can influence infarct volume after middle cerebral artery occlusion (MCAO). In wildtype (WT) and heme oxygenase-2 gene deleted (HO2 -/-) mice, infarcts were not reproducibly achieved with the standard intraluminal filament technique. The present study characterizes a double filament model of MCAO which was developed to produce consistent infarcts in both WT and HO2 -/-mice. Diameters of most cerebral arteries were similar in WT and HO2 -/-mice, although the posterior communicating artery size was variable. In halothane-anesthetized mice, two 6-O monofilaments with blunted tips were inserted into the left internal carotid artery 6.0 and 4.5 mm past the pterygopalatine artery junction to reside distal and proximal to the origin of the MCA. The tissue volume-at-risk determined by brief dye perfusion in WT (59±2% of hemisphere; ±SE) was similar to HO2-/-(62±4%). The volume of tissue with cerebral blood flow <50 ml/min/100g was similar in WT (35±9%) and HO2 -/-(36±11%) during MCAO and at 3 hours of reperfusion (<2%). After 1 hour MCAO, infarct volume was greater in HO2 -/-(44±6%) than WT (25±3%). After increasing MCAO duration to 2 hours, the difference between HO2 -/-(47±4%) and WT (36±3%) diminished, but infarct volume remained substantially less than the volume-at-risk. Infusion of tin protoporphyrin IX, a HO inhibitor, during reperfusion after 1 hour MCAO increased infarct volume in WT but not significantly in HO2 -/-mice, although infarct volume remained less than the volume-at-risk. Thus, greater infarct volume in HO2 -/-mice is not attributable to a greater volume-at-risk, lower intraischemic blood flow or poor reflow, but rather to a neuroprotective effect of HO2 activity. The double filament model may be of use as an alternative in other murine knockout strains in which the standard filament model does not yield consistent infarcts.
Heme oxygenase (HO) converts pro-oxidant heme to biliverdin and carbon monoxide (CO), which can act as a neurotransmitter, vasodilator and anti-apoptotic agent. Biliverdin is rapidly converted to bilirubin, which can protect neurons from oxidative stress at low concentrations (6) . Increasing the expression of the inducible isoform of heme oxygenase, HO1, with a neuronal promoter in transgenic animals provides ischemic protection (22) . However, basal expression of HO1 is normally extremely low in brain and induction after ischemia is delayed 12-48 h with localization occurring primarily in microglia rather than neurons (5, 8, 13, 20) . Thus, this induction probably provides little immediate protection of neurons subjected to focal cerebral ischemia. However, neurons constitutively express heme oxygenase-2 (HO2), which confers resistance to oxidative stress (6) . We have previously shown that infarct volume after 1 h of middle cerebral artery (MCA) occlusion (MCAO) was greater in mice with gene deletion of HO2 (HO2 -/-) (5) and that inhibiting HO activity during reperfusion in wildtype (WT) mice also increased infarct volume (4) . Together, these reports support the concept that endogenous HO activity in neurons is normally protecting neurons after 1 h MCAO.
In assessing the effect of a specific gene deletion in focal ischemic injury, it is important to determine if differences in vascular anatomy and cerebral blood flow (CBF) between WT and knockout animals might account for differences in infarct volume (16-19, 21, 28 ). When we started these studies with the standard intraluminal filament technique, the decrease in laserDoppler flux (LDF) signal was modest and infarcts were small and inconsistent in both WT and HO2 -/-mice, even when larger filaments were tested. To overcome the apparent differences in cerebral vascular anatomy between these strains and C57BL/6 in which the filament technique ordinarily produces large and consistent infarcts, we developed a new procedure in which two filaments are inserted different distances into the same internal carotid artery of the mouse. In the present study, the characteristics of this double filament technique are described in WT and HO2 -/-mice. This model may be of use in other knockout strains of mice in which the standard single filament technique is ineffective.
One approach used to normalize for varability in collateral blood flow during myocardial ischemia is to perfuse a dye during vascular occlusion to determine the volume-at-risk for ischemic injury. We used a similar approach in the brain after insertion of the two filaments.
Using this double filament technique, the first objective of the present investigation was to determine if there are differences between WT and HO2 -/-mice 1) in the diameter of major cerebral arteries, 2) in the tissue volume-at-risk of injury determined by brief dye perfusion after placement of the filaments, 3) in the time course of cortical perfusion measured by LDF, and 4)
in the distribution of CBF at each coronal level measured by iodoantipyrine (IAP) autoradiography during MCAO and at 3 h of reperfusion where loss of CO generation in HO2
-/-mice could conceivably result in poor intraischemic CBF or poor reflow. Analysis was performed at different coronal levels as well as on overall volume because variability in the size of the posterior communicating artery (PcomA) seen in different mouse strains may preferentially affect blood flow distribution in posterior cortex (21) . The second objective was to determine if increasing the duration of ischemia from the 1 h previously used (5) to 2 h results in sustained differences in infarct size between WT and HO2 -/-mice, or if infarct volume approaches the volume-at-risk. Results with infusion of an HO inhibitor (4) were also analyzed in relation to the volume-at-risk to determine if increases in infarct volume approach the volumeat-risk.
METHODS

Focal cerebral ischemia. All procedures were approved by the Johns Hopkins
University Animal Care and Use Committee. Wild-type (WT) and HO2 -/-mice used for breeding were obtained from Kenneth D. Poss and Susumu Tonegawa and have been described previously using embryonic stem cells derived from SV129 mice and C57BL/6 mouse blastocytes (23) .
Mice weighing between 20 and 28g were anesthetized initially with 2% halothane and maintained on 1-1.5% halothane in O 2 -enriched air via a face mask. Rectal temperature was maintained at approximately37ºC during anesthesia with external heating. Focal ischemia was produced by a modification of the intraluminal filament technique. In preliminary experiments on WT and HO2 -/-mice, insertion of either 6-O or 5-O monofilaments with blunted tips 6 mm into the internal carotid artery was found to produce only modest decreases in LDF and usually no infarction, in contrast to our previous experience in mice (24) . To reduce blood flow into the MCA territory from both the anterior and posterior portions of the circle of Willis, two 6-O nylon monofilaments were inserted into the internal carotid artery. Both filaments were blunted by heating and then coating the tip with cyanoacrylate glue. The left external carotid artery was ligated and cut. The common carotid artery was occluded with a silk suture. The first monofilament was inserted into the internal carotid artery through the stump of the external carotid artery and advanced 6.0 mm past the origin of the pterygopalatine artery. The blunted tip lay anterior to the origin of the MCA. The second monofilament was inserted via the external carotid artery and advanced into the internal carotid artery 4.5 mm past the pterygopalatine artery bifurcation. The filament tip lay just proximal to the origin of the middle cerebral artery.
In survival protocols, the neck incision was closed, anesthesia was discontinued and the mouse was allowed to awaken. To establish reperfusion, the mouse was briefly anesthetized with halothane, the suture around the common carotid artery was untied, and both monofilaments were withdrawn through the external carotid artery stump. The neck incision was sutured closed and anesthesia was discontinued. Infarct volume was measured 24 h after induction of ischemia. The skull was thinned with a drill at 3mm posterior and 5mm lateral to the bregma, and a laserDoppler probe (Moor Instruments) was fixed in position. This region represents an area of dense ischemia. Red cell flux during ischemia and reperfusion was expressed as a percent of baseline.
Diameter of cerebral arteries. Five WT and five HO2 -/-mice were anesthetized with halothane and were perfused transcardially at a rate of 6 mL/min with heparinized saline for 5 minutes and then with 10% buffered formalin for 4 minutes. For the final 10 seconds of perfusion, the mouse was perfused with a 1 mL saline solution containing 1.5% Evans Blue and 1.25% albumin. Diameter of major arteries in the base of the brain were measured on a video microscopy system.
Volume-at-risk. After insertion of two 6-O nylon monofilaments into the left internal
carotid artery, seven WT and seven HO2 -/-were perfused transcardially at a rate of 6 mL/min with the descending aorta clamped. Heparinized saline was perfused for 5 minutes followed by a 3 mL saline solution containing 2% Evans Blue for 30 seconds. The whole brain was fixed in 10% buffered formalin for 24 hours. The forebrain was sliced into 2 mm thick coronal sections.
Areas of distinct pallor and areas of light blue, which were in contrast to areas of dark blue, were considered to be areas at risk of infarction. These areas were digitally imaged and numerically integrated on both the anterior and posterior surfaces of each slice to obtain a volume at risk for each coronal slice.
Intraischemic blood flow. Ischemia was produced in five WT and five HO2 -/-mice for 60 minutes. After confirming neurological deficit, the mice were re-anesthetized with halothane and the femoral artery and vein were catheterized. At 60 minutes of ischemia, 4 µCi of [ Regional blood flow during reperfusion. Ischemia was produced in four WT and four HO2 -/-mice for 60 minutes followed by three hours of reperfusion. At 140 minutes of reperfusion, mice were re-anesthetized with halothane and a femoral artery and vein were catheterized. At three hours of reperfusion, IAP was infused and regional CBF was measured as described above.
Statistical analysis. Data are expressed as mean±SE and were subjected to analysis of variance (ANOVA) and, where appropriate, the Newman-Keuls multiple range test at P<.05.
RESULTS
Arterial diameter. The diameter of the left PcomA was small in both WT and HO2
-/-mice ( Figure 1) . Interestingly, the diameter of the right PcomA was larger than that of the left artery in WT mice, but not in HO2 -/-mice in these cohorts. In the present model, the filaments are inserted on the left side. There were no other differences in the diameter of major arteries between WT and HO2 -/-mice. Differences in the MCA supply territory also need to be considered because this can differ among strains (17) and lead to differences in infarct volume (19) . The equivalent volumeat-risk derived from dye perfusion in the WT and HO2 -/-mice in the present study implies a similar overall MCA supply territory, although we cannot exclude possible differences in the precise location of watershed border regions between the MCA and other cerebral arteries (17) .
Volume-at-risk.
Volume-at-risk assessment is commonly used as a within-subject normalization procedure for analyzing infarct data in isolated hearts subjected to coronary artery occlusion, but it is rarely used in focal cerebral ischemia where animals are allowed to survive the surgery and where ischemia is often transient. We analyzed the volume-at-risk in separate cohorts not used for survival studies. With the double filament technique, the coefficient of variation was ~10% in these strains of mice. This variation is reasonably small and suggests that the use of two Evans Blue dye is sometimes used to assess blood-brain barrier disruption. We do not believe that assessment of the volume-at risk is confounded by the use of this dye because the duration of dye perfusion was relatively brief (30 s), whereas much longer circulatory times (~30 min) are generally used to detect extravasation (14) . Moreover, the dye perfusion was performed within 20 minutes of filament insertion, whereas barrier disruption generally requires several hours of ischemia (2) . Lastly, if extravasation were to occur, it would occur first in the ischemic core, but the dye did not reach the ischemic core in substantial amounts with the brief 30 s perfusion.
Increasing the duration of ischemia from 1 h to 2 h in WT mice increased infarct volume from 25% to 36% of hemispheric volume, but infarct volume remained less than the volume-atrisk (~60% of hemisphere). Infarct volume in HO2 -/-mice was also less than the volume-at-risk.
The 85% reduction in LDF over the 2 h MCAO period in lateral parietal cortex indicates that the reduction blood flow was severe and stable in the ischemic core. The issue of whether the flow reduction was equivalent in ischemic border regions was not distinguished by this probe location. However, the IAP autoradiographic data did not reveal any differences in the volume of tissue with low or intermediate levels of CBF. One limitation of the IAP technique is that some of the tracer may diffuse from high flow regions to low flow regions prior to freezing (12) .
However, this error should be similar in both the WT and HO2 -/-mice. In terms of the volume of tissue with low CBF, 35% of the hemisphere in WT mice had CBF <50 ml/min/100g. This volume of tissue is similar to the 36% infarct volume obtained after 2 h MCAO in WT mice.
These results in the mouse are in general agreement with those in the rat where tissue with CBF <50ml/min/100g was destined to infarct (9, 11).
After removal of both filaments, the LDF signal rapidly returned to near-baseline levels.
Not all studies using the single filament technique in mice report complete reperfusion measured by LDF (3). Because reperfusion deficits can be heterogeneous and may influence outcome, we chose to measure the spatial distribution of absolute blood flow by autoradiography. The 3 h time of reperfusion was chosen rather than a shorter time point to allow time for secondary energy failure, cell swelling, thrombus formation and leukocyte adhesion to evolve and because LDF did not reveal a grossly abnormal deficit during the first hour of reperfusion. No evidence of hypoperfusion was seen at 3 h in the reperfused regions in either WT or HO2 -/-groups, and the blood flow distribution was similar to that in the contralateral hemisphere. It is possible that ischemic durations longer than 1 h would reveal reperfusion deficits. Nevertheless, these data indicate that a reperfusion deficit is unlikely to account for the greater infarct volume in HO2
-/-after 1 h of MCAO.
Administration of the HO inhibitor SnPPIX increased infarct volume WT mice, but infarct volume remained less than the volume-at-risk at each coronal level. In HO2 -/-mice, SnPPIX increased infarction only in the second anterior section. In the remaining sections, infarct volume remained substantially less than the volume-at-risk, thereby indicating that the lack of effect of SnPPIX in these sections of HO2 -/-mice was not attributable to inducing a maximum insult. The lack of an effect of SnPPIX on total infarct volume in HO2 -/-mice implies that the primary effect of SnPPIX in WT mice is mediated by inhibition of HO2 activity rather than HO1 activity. The similar infarct volume previously observed in WT and HO1 -/-mice (5) is consistent with this conclusion. Therefore, the neuronally constitutive isoform of HO (HO2) is primarily responsible for providing neuroprotection. Further, the observation that SnPPIX augmented injury when infused only during reperfusion implies that HO2 ordinarily acts to protect neurons after the ischemic insult. However, it is possible that differences in infarct volume between groups may be reduced if reperfusion was extended beyond one day.
The differences in infarct volume between WT and HO2 -/-mice were greater after 1 h ischemia than after 2 h ischemia. Indeed, increasing the duration of ischemia from 1 h to 2 h did not produce a significant increase in infarct volume in HO2 -/-mice. These data indicate that constitutive HO2 provides neuroprotection primarily after relatively brief periods of transient focal cerebral ischemia. Apoptotic mechanisms of cell death may be more prominent after brief periods of ischemia (7). We reported that evoked apoptosis in cerebellar granule cells was enhanced in cultures from HO2 -/-mice (4). After 1 h of MCAO, the number of cells with apoptotic bodies was also enhanced in HO2 -/-mice (4). Thus, constitutive HO2 may provide protection from 1 h of focal ischemia by limiting apoptotic mechanisms of cell death, whereas this neuroprotection may become overwhelmed by necrotic cell death mechanisms when ischemic duration is prolonged.
During ischemia and reperfusion, there is presumably an increase in the load of free heme as heme-containing proteins are degraded by the denaturing effects of oxidant and acidic damage and from active proteolysis. The mechanism of protection by HO2 may be mediated by removal of pro-oxidant heme, the substrate for HO, or by formation of CO and bilirubin. Our data indicate that CO-mediated vasodilation, which would result in enhanced perfusion during ischemia or improved reflow in WT mice, does not account for smaller infarcts in WT mice.
The data do not exclude an anti-apoptotic effect of CO as described in endothelial cells (25) .
Bilirubin in low concentrations is a potent antioxidant that can limit oxidative injury in endothelial cells and neurons (5, 26) , possibly by being oxidized back to biliverdin by reactive oxygen species (1). However, neuroprotection is lost at high concentrations of bilirubin (5).
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